Eastman Chemical Q2 Revenue Jumps 10%, Beats Estimates; Guides Q3 EPS Near $1.97
EMN sits 27% above its 52-week low of $56.11 on elevated volume (1.8× avg).
Summary
Eastman Chemical delivered a strong Q2, with revenue up 10% to $2.51B, beating the $2.40B consensus. Adjusted EPS of $1.97 also topped estimates by $0.15, driven by higher volume and pricing, especially in Chemical Intermediates and Advanced Materials. The company achieved a 350-basis-point sequential adjusted EBIT margin improvement through disciplined cost management. This follows a weak Q1 where earnings dropped 41% on a 5% revenue decline, making the rebound notable. Management guided Q3 adjusted EPS to approach $1.97, signaling confidence in sustained momentum, though full-year operating cash flow is now expected to approach $900M, modestly below prior expectations. The stock, trading at a compressed 10x forward P/E, may see relief as the beat and guidance challenge bearish sentiment.
At the time of this announcement, EMN was trading at $71.37 on NYSE in the Manufacturing sector, with a market capitalization of approximately $8B. The 52-week trading range was $56.11 to $83.47. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.